Suzanne Tavitian

3.4k total citations
59 papers, 857 citations indexed

About

Suzanne Tavitian is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Suzanne Tavitian has authored 59 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 16 papers in Public Health, Environmental and Occupational Health and 15 papers in Genetics. Recurrent topics in Suzanne Tavitian's work include Acute Myeloid Leukemia Research (30 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Suzanne Tavitian is often cited by papers focused on Acute Myeloid Leukemia Research (30 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Suzanne Tavitian collaborates with scholars based in France, United States and Réunion. Suzanne Tavitian's co-authors include Christian Récher, Françoise Huguet, Éric Delabesse, Sarah Bertoli, Emilie Bérard, Audrey Sarry, Anne Huynh, François Vergez, Michel Attal and Isabelle Luquet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.

In The Last Decade

Suzanne Tavitian

56 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne Tavitian France 14 463 200 172 149 130 59 857
Martine J. Hollestelle Netherlands 16 411 0.9× 133 0.7× 90 0.5× 132 0.9× 44 0.3× 33 837
Angela R. Smith United States 19 425 0.9× 371 1.9× 134 0.8× 34 0.2× 208 1.6× 50 1.1k
William E. Beschorner United States 9 662 1.4× 102 0.5× 84 0.5× 123 0.8× 170 1.3× 11 1.1k
Z. Tellier France 15 550 1.2× 198 1.0× 87 0.5× 282 1.9× 71 0.5× 31 1.1k
Federico Chiurazzi Italy 16 164 0.4× 162 0.8× 271 1.6× 82 0.6× 136 1.0× 32 692
Josep Martí Spain 19 368 0.8× 153 0.8× 116 0.7× 471 3.2× 194 1.5× 59 1.3k
Atsuo Maruta Japan 19 1.0k 2.2× 217 1.1× 286 1.7× 75 0.5× 254 2.0× 67 1.5k
Pietro Sodani Italy 20 870 1.9× 158 0.8× 833 4.8× 58 0.4× 153 1.2× 43 1.4k
Jean Norden United Kingdom 18 432 0.9× 261 1.3× 84 0.5× 35 0.2× 135 1.0× 45 1.0k
Eliot Heher United States 12 212 0.5× 185 0.9× 83 0.5× 81 0.5× 177 1.4× 21 863

Countries citing papers authored by Suzanne Tavitian

Since Specialization
Citations

This map shows the geographic impact of Suzanne Tavitian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Tavitian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Tavitian more than expected).

Fields of papers citing papers by Suzanne Tavitian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Tavitian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Tavitian. The network helps show where Suzanne Tavitian may publish in the future.

Co-authorship network of co-authors of Suzanne Tavitian

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Tavitian. A scholar is included among the top collaborators of Suzanne Tavitian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Tavitian. Suzanne Tavitian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faguer, Stanislas, et al.. (2025). Prevention and Treatment of Acute Kidney Injury Associated with High-Dose Methotrexate. Kidney360. 6(3). 476–481. 2 indexed citations
2.
Alliot, Jean‐Marc, Pierre‐Yves Dumas, François Vergez, et al.. (2024). Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study. Leukemia Research. 136. 107437–107437. 10 indexed citations
3.
Leroy, Harmony, Emilie Bérard, Isabelle Luquet, et al.. (2024). Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy. Cancer Medicine. 13(3). e7003–e7003. 1 indexed citations
4.
5.
Bertoli, Sarah, et al.. (2023). A case of acute megakaryoblastic leukaemia following a mediastinal germ cell tumour. SHILAP Revista de lepidopterología. 5(2). 410–411. 1 indexed citations
6.
Boët, Emeline, Ambrine Sahal, Estelle Saland, et al.. (2023). Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms. Blood Cancer Journal. 13(1). 106–106. 8 indexed citations
7.
Rieu, Jean‐Baptiste, et al.. (2023). Acute promyelocytic leukaemia associated with atypical basophilia. British Journal of Haematology. 201(6). 1017–1017. 2 indexed citations
8.
Mouchel, Pierre‐Luc, Emilie Bérard, Suzanne Tavitian, et al.. (2023). Vitamin C and D supplementation in acute myeloid leukemia. Blood Advances. 7(22). 6886–6897. 10 indexed citations
9.
Bertoli, Sarah, Laëtitia Largeaud, Jean‐Baptiste Rieu, et al.. (2022). Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia. Clinical Cancer Research. 29(1). 134–142. 11 indexed citations
10.
Rieu, Jean‐Baptiste, Jill Corre, Suzanne Tavitian, et al.. (2020). A case of cup‐like blasts associated with B‐lymphoblastic leukemia without NPM1 and FLT3 internal tandem duplication mutations. SHILAP Revista de lepidopterología. 1(2). 589–592. 1 indexed citations
11.
Tavitian, Suzanne, Sarah Bertoli, Françoise Huguet, et al.. (2020). Dactinomycin in acute myeloid leukemia with NPM1 mutations. European Journal Of Haematology. 105(3). 302–307. 9 indexed citations
12.
Vergez, François, Marie-Laure Nicolau-Travers, Sarah Bertoli, et al.. (2020). CD34+CD38−CD123+ Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents. Cancers. 12(5). 1174–1174. 11 indexed citations
13.
Obéric, Lucie, Stanislas Faguer, Suzanne Tavitian, et al.. (2020). Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult Patients. Therapeutic Drug Monitoring. 43(3). 408–415. 12 indexed citations
14.
Tavitian, Suzanne, et al.. (2019). Multiple Severe Toxicities of L-Asparaginase and Their Innovative Management during Induction Therapy of Acute Lymphoblastic Leukemia in an Adult Patient. SHILAP Revista de lepidopterología. 2019. 1–6. 7 indexed citations
15.
Largeaud, Laëtitia, Emilie Bérard, Sarah Bertoli, et al.. (2019). Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors. Leukemia Research. 81. 82–87. 6 indexed citations
16.
Étienne, Gabriel, Stéphanie Dulucq, Françoise Huguet, et al.. (2019). Incidence and outcome of BCR‐ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors. Cancer Medicine. 8(11). 5173–5182. 15 indexed citations
17.
Bertoli, Sarah, Étienne Paubelle, Emilie Bérard, et al.. (2018). Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia. European Journal Of Haematology. 102(2). 131–142. 69 indexed citations
18.
Comont, Thibault, Suzanne Tavitian, Laurent Bardiaux, et al.. (2017). Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy. Leukemia Research. 61. 62–67. 29 indexed citations
19.
Ribes, David, Lucie Obéric, François Vergez, et al.. (2017). Bendamustine plus rituximab for indolent B‐cell lymphoma of renal significance. American Journal of Hematology. 93(3). 356–362. 5 indexed citations
20.
Tavitian, Suzanne, Jean‐Marie Péron, Anne Huynh, et al.. (2010). Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. Journal of Clinical Virology. 49(2). 141–144. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martine J. Hollestelle Breakdown of academic impact, for papers by Angela R. Smith Breakdown of academic impact, for papers by William E. Beschorner Breakdown of academic impact, for papers by Z. Tellier Breakdown of academic impact, for papers by Federico Chiurazzi Breakdown of academic impact, for papers by Josep Martí Breakdown of academic impact, for papers by Atsuo Maruta Breakdown of academic impact, for papers by Pietro Sodani Breakdown of academic impact, for papers by Jean Norden Breakdown of academic impact, for papers by Eliot Heher
Rankless by CCL
2026